Charting Her Own Course

Telomeres » TeloYears in the news » Charting Her Own Course

March 29, 2017 | Amy | Leave a comment

NYT/SAN FRANCISCO, CA (14 SEP 2011): UCSF Scientists portraits for video shoot. Dr. Elizabeth Blackburn is a nobel laureate. CREDIT PHOTO TO: JIM WILSON/THE NEW YORK TIMES NYTCREDIT: Jim Wilson/The New York Times

New York Times 2011 interview with our founder, Elizabeth Blackburn, on her work in telomere biology and her decision to start the company that makes TeloYears.

Leave a Reply Cancel reply

The TeloYears test is not intended for screening, diagnosing, treating or preventing diseases or medical conditions. The TeloYears genetic test may indicate the possibility of identifying a rare telomere syndrome associated with extremely shorter or longer average telomere length (ATL). In these rare cases, further testing and consultation with a doctor to rule in or rule out a telomere syndrome is recommended. The test is available for individuals between the ages of 20 to 80 within the United States, except for the states of Maryland and New York. The information provided by the TeloYears test should not be used to replace medically appropriate screening tests recommended based upon actual age or other risk factors, nor should the information be used to make decisions about diagnosis or treatment of diseases or medical conditions. The Telomere Diagnostics lab is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by Telomere Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration.